Fresh2 Group Ltd's ability to collect accounts receivable sequentially worsen to 1.73, indicating more challenging environment then in the third quarter 2022, but still, it is a far cry from any concerns. Fresh2 Group Ltd's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 211 days, from 96 days, in the 0 quarter.

If we take a look into Healthcare sector 441 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 0 to 3170.

What is Receivable Turnover Ratio?
What is Fresh2 Group Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ANPC Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	164.49 %	-47.28 %	-77.81 %	-22.76 %	141.35 %
Y / Y Revenue Change	-38.13 %	-	-	-	-
Receivable Turnover Ratio (TTM)	1.73	3.79	3.23	1.96	1.86
ANPC's Total Ranking	# 3170	# 0	# 3962	# 0	# 0
Accounts Receivable average collection period days	211	96	113	186	196
Seq. Receivable Change	191.75 %	-9.35 %	-42.16 %	72.9 %	-41.85 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 31
Healthcare Sector	# 442
Overall Market	# 3170

Receivable Turnover Ratio Statistics
High	Average	Low
0.3	0.3	0.3
(Dec 31 2022)

ANPC Company Profile • Back to ANPC Efficiency Comparisons • Compare ANPC Receivables Turnover Ratio to its Competitors

Financial Statements
Fresh2 Group Ltd's Accounts Receivable	$ 2 Millions	Visit ANPC's Balance sheet
Fresh2 Group Ltd's Sales TTM	$ 2 Millions	Visit ANPC's Income Statement
Sources of ANPC's Revenues		Visit ANPC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ANPC's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ANPC's Growth Rates	ANPC's Roa	ANPC's Inventory Turnover Ratio	ANPC's Dividend Comparisons
ANPC's Profitability Ratios	ANPC's Roi	ANPC's Asset Turnover Ratio	ANPC's Dividend Growth
ANPC's Valuation Ratios	ANPC's Roe	ANPC's Financial Strength Ratios	ANPC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Optinose Inc	2.80	$ 76.276 Millions	$ 27.254 Millions
Alimera Sciences Inc	2.78	$ 54.129 Millions	$ 19.462 Millions
Amneal Pharmaceuticals Inc	2.75	$ 2,199.269 Millions	$ 800.214 Millions
Dermtech Inc	2.74	$ 14.518 Millions	$ 5.308 Millions
Baudax Bio Inc	2.71	$ 1.269 Millions	$ 0.468 Millions
Genetron Holdings Ltd	2.68	$ 94.344 Millions	$ 35.250 Millions
Oak Street Health Inc	2.66	$ 2,160.900 Millions	$ 812.650 Millions
Olink Holding Ab publ	2.65	$ 139.848 Millions	$ 52.743 Millions
Evofem Biosciences Inc	2.63	$ 16.837 Millions	$ 6.402 Millions
Fortress Biotech Inc	2.60	$ 75.743 Millions	$ 29.149 Millions
Sorrento Therapeutics Inc	2.56	$ 62.840 Millions	$ 24.512 Millions
Esperion Therapeutics Inc	2.55	$ 75.475 Millions	$ 29.545 Millions
Abeona Therapeutics Inc	2.53	$ 1.845 Millions	$ 0.729 Millions
Journey Medical Corp	2.53	$ 73.669 Millions	$ 29.149 Millions
Erytech Pharma S a	2.51	$ 0.204 Millions	$ 0.081 Millions
Genmab A	2.50	$ 2,053.672 Millions	$ 821.705 Millions
Therapeuticsmd Inc	2.47	$ 69.963 Millions	$ 28.344 Millions
Sientra Inc	2.47	$ 90.549 Millions	$ 36.704 Millions
Heron Therapeutics Inc	2.45	$ 107.672 Millions	$ 43.911 Millions
Acutus Medical Inc	2.45	$ 16.363 Millions	$ 6.677 Millions
Chinook Therapeutics Inc	2.43	$ 6.128 Millions	$ 2.518 Millions
Ocular Therapeutix Inc	2.43	$ 51.494 Millions	$ 21.204 Millions
Scynexis Inc	2.41	$ 5.091 Millions	$ 2.108 Millions
Sab Biotherapeutics Inc	2.40	$ 23.904 Millions	$ 9.974 Millions
Avricore Health Inc	2.39	$ 1.360 Millions	$ 0.569 Millions
Biontech Se	2.39	$ 18,235.540 Millions	$ 7,644.363 Millions
Immuneering Corporation	2.35	$ 0.317 Millions	$ 0.135 Millions
Regeneron Pharmaceuticals Inc	2.33	$ 12,172.900 Millions	$ 5,219.350 Millions
Impel Pharmaceuticals Inc	2.27	$ 12.652 Millions	$ 5.563 Millions
Biocept Inc	2.27	$ 21.278 Millions	$ 9.371 Millions

Date modified: 2026-10-07T00:41:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.